Shenzhen Lifotronic Technology Co (688389) - Net Assets

Latest as of March 2026: CN¥2.14 Billion CNY ≈ $313.58 Million USD

Based on the latest financial reports, Shenzhen Lifotronic Technology Co (688389) has net assets worth CN¥2.14 Billion CNY (≈ $313.58 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥2.53 Billion ≈ $369.58 Million USD) and total liabilities (CN¥382.72 Million ≈ $56.00 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check 688389 PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.

Key Net Assets Metrics

Metric	Value
Current Net Assets	CN¥2.14 Billion
% of Total Assets	84.85%
Annual Growth Rate	21.31%
5-Year Change	67.63%
10-Year Change	N/A
Growth Volatility	19.48

Shenzhen Lifotronic Technology Co - Net Assets Trend (2016–2025)

This chart illustrates how Shenzhen Lifotronic Technology Co's net assets have evolved over time, based on quarterly financial data. For live market cap and overall valuation, see market value of Shenzhen Lifotronic Technology Co.

Annual Net Assets for Shenzhen Lifotronic Technology Co (2016–2025)

The table below shows the annual net assets of Shenzhen Lifotronic Technology Co from 2016 to 2025. Also explore 688389 shareholders equity momentum to track the company's year-over-year net asset growth rate.

Year	Net Assets	Change
2025-12-31	CN¥2.11 Billion ≈ $308.57 Million	+2.90%
2024-12-31	CN¥2.05 Billion ≈ $299.89 Million	+14.01%
2023-12-31	CN¥1.80 Billion ≈ $263.05 Million	+24.53%
2022-12-31	CN¥1.44 Billion ≈ $211.23 Million	+14.75%
2021-12-31	CN¥1.26 Billion ≈ $184.08 Million	+10.00%
2020-12-31	CN¥1.14 Billion ≈ $167.34 Million	+8.95%
2019-12-31	CN¥1.05 Billion ≈ $153.60 Million	+57.04%
2018-12-31	CN¥668.39 Million ≈ $97.81 Million	+13.82%
2017-12-31	CN¥587.25 Million ≈ $85.93 Million	+58.36%
2016-12-31	CN¥370.82 Million ≈ $54.26 Million	--

Equity Component Analysis

This analysis shows how different components contribute to Shenzhen Lifotronic Technology Co's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have grown by 1952.5% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2025)

Component	Amount	Percentage
Retained Earnings	CN¥929.52 Million	43.93%
Other Components	CN¥1.19 Billion	56.07%
Total Equity	CN¥2.12 Billion	100.00%

Shenzhen Lifotronic Technology Co Competitors by Market Cap

The table below lists competitors of Shenzhen Lifotronic Technology Co ranked by their market capitalization.

Company	Market Cap
Beijing WKW Automotive Parts Co Ltd SHE:002662	$698.00 Million
Peoples Fin NASDAQ:PFIS	$698.02 Million
Argus Shanghai Textile Chemicals Co Ltd SHG:603790	$698.09 Million
Dakota Gold Corp. NYSE MKT:DC	$698.29 Million
Ruitai Materials Technology Co Ltd SHE:002066	$697.80 Million
Tronox Holdings PLC NYSE:TROX	$697.65 Million
Jaya Sukses Makmur Sentosa Tbk PT JK:RISE	$697.64 Million
Shenzhen Sunwin Intelligent SHE:300044	$697.50 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Shenzhen Lifotronic Technology Co's equity between the two most recent reporting periods.

Equity Growth Insights

From 2024 to 2025, total equity changed from 2,050,964,593 to 2,115,784,957, a change of 64,820,364 (3.2%).
Net income of 186,094,700 contributed positively to equity growth.
Dividend payments of 120,832,975 reduced retained earnings.
Other comprehensive income decreased equity by 132,273,059.
Other factors increased equity by 131,831,698.

Equity Change Factors (2024 to 2025)

Factor	Impact	Contribution
Net Income	CN¥186.09 Million	+8.8%
Dividends Paid	CN¥120.83 Million	-5.71%
Other Comprehensive Income	CN¥-132.27 Million	-6.25%
Other Changes	CN¥131.83 Million	+6.23%
Total Change	CN¥-	3.16%

Book Value vs Market Value Analysis

This analysis compares Shenzhen Lifotronic Technology Co's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 2.28x
The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
The price-to-book ratio has increased from 1.55x to 2.28x over the analyzed period, suggesting growing market confidence.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2016-12-31	CN¥7.18	CN¥11.13	x
2017-12-31	CN¥1.67	CN¥11.13	x
2018-12-31	CN¥1.73	CN¥11.13	x
2019-12-31	CN¥2.71	CN¥11.13	x
2020-12-31	CN¥2.70	CN¥11.13	x
2021-12-31	CN¥2.97	CN¥11.13	x
2022-12-31	CN¥3.44	CN¥11.13	x
2023-12-31	CN¥4.21	CN¥11.13	x
2024-12-31	CN¥4.81	CN¥11.13	x
2025-12-31	CN¥4.89	CN¥11.13	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Shenzhen Lifotronic Technology Co utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): 8.80%
The company has moderate efficiency in generating returns from equity.
DuPont Analysis Breakdown:
• Net Profit Margin: 17.93%
• Asset Turnover: 0.37x
• Equity Multiplier: 1.33x
Recent ROE (8.80%) is below the historical average (12.33%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2016	2.80%	5.95%	0.35x	1.34x	CN¥-26.70 Million
2017	9.61%	22.50%	0.35x	1.21x	CN¥-2.30 Million
2018	12.14%	25.09%	0.40x	1.21x	CN¥14.30 Million
2019	9.58%	23.79%	0.36x	1.12x	CN¥-4.41 Million
2020	12.59%	25.99%	0.43x	1.13x	CN¥29.65 Million
2021	15.16%	24.46%	0.53x	1.17x	CN¥64.80 Million
2022	17.47%	25.58%	0.54x	1.26x	CN¥107.50 Million
2023	18.29%	28.68%	0.49x	1.30x	CN¥148.91 Million
2024	16.84%	30.09%	0.40x	1.41x	CN¥140.30 Million
2025	8.80%	17.93%	0.37x	1.33x	CN¥-25.48 Million

Industry Comparison

This section compares Shenzhen Lifotronic Technology Co's net assets metrics with peer companies in the Medical Devices industry.

Industry Context

Industry: Medical Devices
Average net assets among peers: $3,326,899,819
Average return on equity (ROE) among peers: 19.90%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Shenzhen Lifotronic Technology Co (688389)	CN¥2.14 Billion	2.80%	0.18x	$697.86 Million
Shanghai Kehua Bio-Engineering Co Ltd (002022)	$2.43 Billion	8.55%	0.44x	$465.89 Million
Jiangsu Yuyue Medical Equipment & Supply Co Ltd (002223)	$11.92 Billion	20.11%	0.34x	$3.90 Billion
Double Medical Technology Inc (002901)	$3.18 Billion	11.21%	0.39x	$2.46 Billion
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A (002932)	$49.59 Million	43.44%	0.23x	$525.69 Million
Lepu Medical Tech Beijing (300003)	$10.54 Billion	17.10%	0.73x	$3.13 Billion
INKON Life Technology Co Ltd (300143)	$2.62 Billion	2.62%	0.60x	$854.32 Million
Edan Instruments Inc (300206)	$1.85 Billion	12.58%	0.21x	$992.43 Million
Guangdong Biolight Meditech Co Ltd (300246)	$585.84 Million	11.05%	0.64x	$623.76 Million
Beijing Leadman Biochemistry Co Ltd (300289)	$83.90 Million	31.18%	0.36x	$479.23 Million
Sinocare Inc (300298)	$17.42 Million	41.15%	0.68x	$1.34 Billion

About Shenzhen Lifotronic Technology Co

SHG:688389 China Medical Devices

Market Cap

$697.86 Million

CN¥4.77 Billion CNY

Market Cap Rank

#10731 Global

#2961 in China

Share Price

CN¥11.13

Change (1 day)

+1.09%

52-Week Range

CN¥9.59 - CN¥14.74

All Time High

CN¥37.22